This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:co-infections [06.07.2011] – paulalbert | home:diseases:co-infections [11.13.2011] – paulalbert | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ~~NOTOC~~ | ||
====== Co-infections ====== | ====== Co-infections ====== | ||
+ | < | ||
A variety of bacteria, fungi, and viruses are commonly described as co-infections. These include: // | A variety of bacteria, fungi, and viruses are commonly described as co-infections. These include: // | ||
- | Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections. | + | Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, |
+ | |||
+ | ===== Frequently cited types ===== | ||
+ | |||
+ | * // | ||
+ | * // | ||
+ | * // | ||
+ | * **Cytomegalovirus** – A viral genus of the viral group known as Herpesviridae or herpesviruses. It is typically abbreviated as CMV. The species that infects humans it is commonly known as human CMV (HCMV) or human herpesvirus-5 (HHV-5), and is the best studied of all cytomegaloviruses. | ||
+ | * // | ||
+ | * **Epstein-Barr virus** | ||
+ | * // | ||
+ | |||
+ | |||
+ | ==== Candida albicans ==== | ||
+ | |||
+ | < | ||
+ | |||
+ | //Candida albicans// is a fungus (a form of yeast) that plays a role in opportunistic oral and genital infections in humans. //C. albicans// biofilms readily form on the surface of implantable medical devices. Systemic fungal infections (fungemias) have emerged as important causes of morbidity and mortality in patients traditionally labelled as immunocompromised, | ||
+ | |||
+ | As the section devoted to antimicrobial peptides (AmPs) explains, the AmP cathelicidin is a component of the innate immune system, and is responsive to fungi.(({{pubmed> | ||
+ | |||
+ | Antifungal agents such as fluconazole (Diflucan) are sometimes prescribed to treat fungal infections. While some patients have reported feeling better after taking antifungal agents, antifungals interfere with immune function. | ||
+ | |||
+ | At least according to one study, patients are a poor judge of whether they have fungal infections. | ||
+ | |||
+ | < | ||
+ | Patient symptom scores were a poor predictor of yeast infections based on yeast culture results. ... Self-reported symptoms are not reliable for diagnosis. | ||
+ | |||
+ | //**Susan Hoffstetter** et al.// (({{pubmed> | ||
Line 17: | Line 45: | ||
- | ===== Marshall Protocol targets co-infections ===== | + | ===== Marshall Protocol targets |
< | < | ||
- | Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes | + | Using the VDR agonist, olmesartan, the MP activates the innate immune response. The innate immune response is effective against a range of microbes including |
{{section>: | {{section>: | ||
+ | |||
+ | |||
+ | Some evidence has emerged that using a therapy to target a given infection aids the body in its ability to eliminate otherwise unrelated pathogens. For example, a 2011 //Science// study gave two groups of mice an injection of poliovirus, a gut virus. One group was treated with antibiotics, | ||
+ | |||
+ | |||